Related Experiment Video
Updated: Oct 28, 2025
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
379
Ca2+/calmodulin-dependent Protein Kinases in Leukemia Development.
Changhao Cui1, Chen Wang2, Min Cao2
1School of Life Science and Medicine, Dalian University of Technology, Liaoning 124221, China.
Journal of Cellular Immunology
|July 15, 2021
Summary
Calcium/calmodulin (CaM) signaling influences cell functions and cancer. This study reviews the role of Ca2+/CaM-dependent protein kinases (CaMKs) in leukemia development, focusing on CaMKI, CaMKII, and CaMKIV.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Signal Transduction
Background:
- Calcium/calmodulin (CaM) signaling regulates diverse cellular processes.
- CaM signaling is implicated in tumor progression, including proliferation, invasion, and migration.
- The specific role of CaM signaling in leukemia remains underexplored.
Purpose of the Study:
- To summarize the function and mechanisms of Ca2+/CaM-dependent protein kinases (CaMKs) in leukemia.
- To highlight the significance of CaMKs in myeloid leukemia development.
- To consolidate current understanding of CaMK signaling in leukemogenesis.
Main Methods:
- Literature review and synthesis of existing research on CaMKs in leukemia.
- Analysis of studies focusing on CaMKI, CaMKII, and CaMKIV.
- Integration of data on kinase function and molecular mechanisms in leukemic cells.
Main Results:
- CaMKs are crucial intermediates in Ca2+/CaM signaling pathways.
- CaMKI, CaMKII, and CaMKIV are the most studied CaMKs in the context of leukemia.
- These kinases play significant roles in the development and progression of myeloid leukemia.
Conclusions:
- Ca2+/CaM signaling, mediated by CaMKs, is a critical factor in leukemia.
- Understanding CaMK pathways offers potential therapeutic targets for leukemia treatment.
- Further research into CaMK mechanisms is essential for advancing leukemia therapy.
Related Concept Videos
01:16Calmodulin-dependent Signaling
5.5K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.5K
01:07MAPK Signaling Cascades
6.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.7K
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K
02:15M-Cdk Drives Transition Into Mitosis
5.8K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.8K
01:22PI3K/mTOR/AKT Signaling Pathway
4.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.3K
01:15Differentiation of Common Myeloid Progenitor Cells
3.6K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.6K